As of Oct 24
| +0.275 / +1.84%|
The 9 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 19.72, with a high estimate of 24.42 and a low estimate of 15.61. The median estimate represents a +29.84% increase from the last price of 15.19.
The current consensus among 9 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.